Semaglutide decreases cardiovascular risk score after one year of useTwo new studies presented at this year's European Congress on Obesity have revealed that semaglutide is effective for weight loss in a...
SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events2 days ago